JOURNAL OF MEDICAL INTERNET RESEARCH Zola Matuvanga et al Original Paper Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study Trésor Zola Matuvanga1,2,3, MD; Ginger Johnson4, PhD; Ynke Larivière2,3, MPH; Emmanuel Esanga Longomo5, MD; Junior Matangila1, PhD; Vivi Maketa1, PhD; Bruno Lapika6, PhD; Patrick Mitashi1, PhD; Paula Mc Kenna7, MSc; Jessie De Bie2,3, PhD; Jean-Pierre Van Geertruyden2, PhD; Pierre Van Damme3, PhD; Hypolite Muhindo Mavoko1, PhD 1Department of Tropical Medicine, University of Kinshasa, Kinshasa, the Democratic Republic of the Congo 2Global Health Institute, University of Antwerp, Antwerp, Belgium 3Centre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium 4Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium 5Division Provinciale de la Santé de la Province de la Tshuapa, Boende, the Democratic Republic of the Congo 6Department of Anthropology, University of Kinshasa, Kinshasa, the Democratic Republic of the Congo 7Janssen Pharmaceutica NV, Beerse, Belgium Corresponding Author: Trésor Zola Matuvanga, MD Department of Tropical Medicine University of Kinshasa Avenue Université numéro 1, Commune de Lemba Kinshasa the Democratic Republic of the Congo Phone: 243 810046306 Email:
[email protected] Abstract Background: A partnership between the University of Antwerp and the University of Kinshasa implemented the EBOVAC3 clinical trial with an Ebola vaccine regimen administered to health care provider participants in Tshuapa Province, Democratic Republic of the Congo. This randomized controlled trial was part of an Ebola outbreak preparedness initiative financed through Innovative Medicines Initiative-European Union.